DECIPHERA PHARMACEUTICALS IN
CUSIP 24344T101
Deciphera Pharmaceuticals In has 2 institutional holders in Filings Flow’s 13F database, together reporting 392.2K shares worth $6M as of Q1 2025. The largest reported holders are Norges Bank, Dekabank Deutsche Girozentrale, and Legal & General Group PLC.
Institutional Holders
2
Q1 2025
Reported Value
$6M
Ticker
unmapped
private placement or foreign
Quarters Tracked
25
Ownership Trend
Institutional holders
Total reported value
Holders
Mixed quarters
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| TUCKER ASSET MANAGEMENT LLC$343M AUM | 0.00% | $15,730 | 1.0K | Q2 2024OLDER |
| DekaBank Deutsche Girozentrale$60.6B AUM | 0.00% | $759,000 | 50.0K | Q2 2024OLDER |
| Legal & General Group Plc$432.4B AUM | 0.00% | $647,941 | 40.2K | Q1 2025 |
| ROTHSCHILD INVESTMENT LLC$1.9B AUM | 0.00% | $157 | 10 | Q2 2024OLDER |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.